CLOs on the Move

Futuri Media

www.futurimedia.com

 
Futuri is the only company focused on growing results for media organizations with a full suite of innovative, AI-powered audience engagement and sales intelligence solutions. We keep brands ahead of the competition. Futuri partners benefit from our 10+ years of deep roots in technology innovation for broadcast media and publishers. Our solutions help media organizations draw audiences in, keep them engaged, and inspire them to take actions that positively impact your bottom line.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.futurimedia.com
  • 4141 Rockside Road Suite 300
    Seven Hills, OH USA 44131
  • Phone: 877.221.7979

Executives

Name Title Contact Details

Similar Companies

Syntellect

Syntellect Inc. is a Phoenix, AZ-based company in the Software & Internet sector.

Lattix

Lattix is a Andover, MA-based company in the Software and Internet sector.

Digital Rez Software Corp

Digital Rez Software Corp is a Sicamous, BC-based company in the Software & Internet sector.

Blue Shift Technologies

Blue Shift Technologies Inc. is a Pittsford, NY-based company in the Software & Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.